← Eichor
Study identifier: NCT06611228 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Optimizing Prevention of Hospital-Acquired Disability Through Multidomain Interventions

Condition: Frailty Syndrome · Aging  ·  Sponsor: University of Milano Bicocca

PhaseNA
Planned participants288
Who can joinAll sexes, 70 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this study is to assess whether a multidomain, multidisciplinary intervention (MDI), enhanced by technological solutions, effectively improves the functional and cognitive status of older hospitalized patients at risk of disability or worsening frailty. Additionally, the study will evaluate the feasibility and acceptability of delivering these interventions remotely via technology after hospital discharge. Participants will: * Receive an MDI during their hospital stay and continue with remote at-home support for 3 months, or receive usual care. * Attend outpatient clinics for follow-up assessment at 3 and 6 months.

This description comes directly from the study's public registry record.

Talk to the study team

Giuseppe Bellelli, MD  ·  3392777327  ·  giuseppe.bellelli@campus.unimib.it

Giuseppe Bellelli, MD

Always discuss trial participation with your own doctor first.

Locations (1)

Fondazione IRCCS San Gerardo dei TintoriMonza, Lumbardy, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06611228